PepGen Inc. (PEPG)
5.98
+3.59
(+150.21%)
USD |
NASDAQ |
Nov 10, 10:07
PepGen Cash and Short Term Investments (Quarterly) : 117.24M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 117.24M |
| March 31, 2026 | 132.30M |
| December 31, 2025 | 148.46M |
| September 30, 2025 | 163.66M |
| June 30, 2025 | 74.65M |
| March 31, 2025 | 97.78M |
| December 31, 2024 | 120.19M |
| September 30, 2024 | 138.86M |
| June 30, 2024 | 161.31M |
| March 31, 2024 | 175.22M |
| December 31, 2023 | 110.41M |
| September 30, 2023 | 129.54M |
| Date | Value |
|---|---|
| June 30, 2023 | 147.03M |
| March 31, 2023 | 165.40M |
| December 31, 2022 | 181.75M |
| September 30, 2022 | 195.78M |
| June 30, 2022 | 218.82M |
| March 31, 2022 | 118.85M |
| December 31, 2021 | 132.90M |
| September 30, 2021 | 141.54M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 9.778M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 456.22M |
| IRulya Therapeutics, Inc. | 115.98M |
| Q32 Bio, Inc. | 289.59M |
| Bridgebio Oncology Therapeutics, Inc. | 225.71M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |